[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367158-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-367158-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","stereotactic-body-radiotherapy-with-carbon-ions-as-local-ablative-treatment-in-patients-with-primary-liver-cancer-research-open-access","Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer - Research open access","","Retrospective analysis evaluates hypofractionated carbon ion radiotherapy (CIRT) versus photon-based stereotactic body radiation (SBRT) for primary liver cancer, addressing a clinical gap because no standardized European CIRT protocol exists. Thirty-six patients received CIRT in four fractions and twenty received photon SBRT between 2011 and 2022. Results show superior local tumor control and improved survival and distant progression-free outcomes with CIRT, without observed liver function impairment. Findings support CIRT/SBRT as promising local ablative strategies needing larger prospective trials.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/stereotactic-body-radiotherapy-with-carbon-ions-as-local-ablative-treatment-in-patients-with-primary-liver-cancer-research-open-access/367158/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/stereotactic-body-radiotherapy-with-carbon-ions-as-local-ablative-treatment-in-patients-with-primary-liver-cancer-research-open-access/367158.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-18","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"Why is carbon ion radiotherapy considered for unresectable primary liver cancer?","Question",{"text":63,"@type":64},"The study motivates CIRT because particle therapy with high linear energy transfer may increase efficacy of external beam radiotherapy while limiting toxicity to non-cancerous liver tissue. It also notes limited standardized European data for CIRT in liver cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the study designed and what treatments were compared?",{"text":68,"@type":64},"The retrospective study compared hypofractionated CIRT (four fractions) in 36 patients with photon-based SBRT in 20 patients. Patients were treated between 2011 and 2022 and evaluated for survival, local control, and toxicity.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main outcome differences between CIRT and photon-based SBRT?",{"text":72,"@type":64},"CIRT showed a higher two-year local control rate (92.3%). It also demonstrated significantly longer median distant progression-free survival versus photon-based SBRT, and in matched-pair comparison it had longer two-year overall survival and distant PFS.",{"name":74,"@type":61,"acceptedAnswer":75},"Did either treatment impair liver function?",{"text":76,"@type":64},"No significant impairment of liver function was observed in either the CIRT or photon-based SBRT cohort.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},367158,1790216301,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","Hoffmeister‑Wittmann et al.  \nRadiation Oncology (2025) 20:23  \n[https://doi.org/10.1](https://doi.org/10.1) 186/s13014‑025‑02594‑y  \nRadiation Oncology  \n RESEARCH Open Access  \nStereotactic body radiotherapy with carbon   ions as local ablative treatment in patients with primary liver cancer  \nPaula Hoffmeister‑Wittmann1,2,3,5*, Philipp Hoegen‑Saßmannshausen 1,2,3,4, Livia Wicklein1,2, Fabian Weykamp1,2,3,4, Katharina Seidensaal1,2, Christoph Springfeld3,5,6, Michael T. Dill3,6,7,8,  \nThomas Longerich6,9, Peter Schirmacher6,9, Arianeb Mehrabi6,10, René Michael Mathy11, Bruno C. Köhler3,5,6, Jürgen Debus 1,2,3,4,6,12,13, Klaus Herfarth 1,2,3,12 and Jakob Liermann 1,2,3,6,12  \nAbstract  \nBackground and aims Liver cancer is the third leading cause of cancer related death due to treatment resistance and late onset of symptoms (Rumgay in J Hepatol 77: 1598–1606, 2022) . The role of external beam radiotherapy (EBRT) in treatment of unresectable liver cancer needs to be defined. The use of particle therapy such as carbon ion radiation therapy (CIRT) with high linear energy transfer (LET) could increase efficacy of EBRT while limiting the toxic effects of radiation on non‑cancerous liver tissue. Promising effects of CIRT have been described in several studies during the past decades, mostly in Japan. To date, no standardized treatment protocol has been established and Euro‑ pean data on CIRT for liver cancer is lacking. This retrospective analysis aims to investigate efficacy and safety of hypof‑ ractionated CIRT compared to photon‑based stereotactic body radiation (SBRT) in primary liver cancer.  \nMethod Thirty‑six (n = 36) and twenty (n = 20) patients with primary malignant liver tumors were treated with hypof‑ ractionated CIRT (4 fractions) and photon‑based SBRT, respectively, between 2011 and 2022 and were retrospectively evaluated for survival, local control, and toxicity.  \nResults Two‑year local control rate after CIRT was 92. 3% . Compared to photon‑ based SBRT, CIRT scores with a sig‑ nificantly longer median distant progression free survival (3 .1 versus 0.9 years) . In a matched pair comparison  \nof the two treatment regimens, the CIRT cohort demonstrated both longer 2‑year overall survival (100% versus 59. 6%) and longer 2‑year distant PFS (75 . 7% versus 22. 9%) . No significant impairment of liver function was observed in either cohort.  \nConclusion In this retrospective analysis, patients who received CIRT presented excellent local tumor control and had better oncologic outcomes than patients who received photon‑based SBRT. SBRT with carbon ions  \nis a promising local ablative treatment option that needs further investigation in large prospective trials.  \nKeywords Hepatocellular carcinoma, SBRT, Cholangiocarcinoma, Local control, Carbon ion radiotherapy, Hypofractionation  \n*Correspondence:  \nPaula Hoffmeister‑Wittmann  \npaula.hoffmeister‑wittmann@med.uni‑heidelberg.de  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nHoffmeister‑Wittmann e","cbCaioaMo1RwSHL9","https://ap.wps.com/l/cbCaioaMo1RwSHL9","pdf",1714538,11,"English","# Background and aims\n# Method\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"Why is carbon ion radiotherapy considered for unresectable primary liver cancer?\",\"answer\":\"The study motivates CIRT because particle therapy with high linear energy transfer may increase efficacy of external beam radiotherapy while limiting toxicity to non-cancerous liver tissue. It also notes limited standardized European data for CIRT in liver cancer.\"},{\"question\":\"How was the study designed and what treatments were compared?\",\"answer\":\"The retrospective study compared hypofractionated CIRT (four fractions) in 36 patients with photon-based SBRT in 20 patients. Patients were treated between 2011 and 2022 and evaluated for survival, local control, and toxicity.\"},{\"question\":\"What were the main outcome differences between CIRT and photon-based SBRT?\",\"answer\":\"CIRT showed a higher two-year local control rate (92.3%). It also demonstrated significantly longer median distant progression-free survival versus photon-based SBRT, and in matched-pair comparison it had longer two-year overall survival and distant PFS.\"},{\"question\":\"Did either treatment impair liver function?\",\"answer\":\"No significant impairment of liver function was observed in either the CIRT or photon-based SBRT cohort.\"}]","Stereotactic body radiotherapy with carbon ions as local ablative treatment in patients with primary liver cancer - Research open access | PDF",1790169531,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab31f22a480d1d487438d8cfedca7f95.webp",983,1305,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56b0d2b5597011ed15084b40458bbbc8.webp",982,1304,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b40c6253c1cd68c35ea00e293c5a2cc5.webp",981,1303,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be1dadee55d3f882883d7b277bf5c1d0.webp",980,1301]